Status: Recruiting
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
A first-in-human study using BDC-4182 as a single agent in gastric and gastroesophageal cancers
Participants needed: 122
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Bolt Biotherapeutics, Inc.Updated: Jan 27, 2026Locations: 16
Eligibility criteria
Has disease that is measurable by Response Evaluation Criteria in Solid Tumors (... [+5]
Known central nervous system (CNS) metastases except for disease that is asympto... [+5]